CN Patent

CN112402588B — 一种注射用氧奥曲肽及其制备方法

Assigned to Beijing Cotimes Biotech Co Ltd · Expires 2022-05-27 · 4y expired

What this patent protects

本发明公开一种新的注射用氧奥曲肽，本发明的创新点通过加入磷酸盐缓冲剂起到了保护溶液在相对稳定的体系中完成升华干燥，加入冻干保护剂聚乙烯吡咯烷酮后能够使氧奥曲肽在生产过程中保持原物理或化学状态，保证活性物质大分子结构不被工艺破坏，经过多批次的试验注射用氧奥曲肽加入聚乙烯吡咯烷酮作为保护剂后能够持续稳定的生产出符合预定规格及质量标准的产品。

USPTO Abstract

本发明公开一种新的注射用氧奥曲肽，本发明的创新点通过加入磷酸盐缓冲剂起到了保护溶液在相对稳定的体系中完成升华干燥，加入冻干保护剂聚乙烯吡咯烷酮后能够使氧奥曲肽在生产过程中保持原物理或化学状态，保证活性物质大分子结构不被工艺破坏，经过多批次的试验注射用氧奥曲肽加入聚乙烯吡咯烷酮作为保护剂后能够持续稳定的生产出符合预定规格及质量标准的产品。

Drugs covered by this patent

Patent Metadata

Patent number
CN112402588B
Jurisdiction
CN
Classification
—
Expires
2022-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Cotimes Biotech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.